FINWIRES · TerminalLIVE
FINWIRES

$AMRN

27 stories mentioning AMRNUpdated 2d ago

Every FINWIRES story that references AMRN, newest first.

What's the latest news on AMRN?

Asia Markets

European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading

European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.41% to 1,938.57 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and accommodations booking site trivago (TRVG), which advanced 1.6% and 1.1% respectively. They were followed by medical device maker EDAP TMS (FOCL) and 3D printer company Materialise (MTLS), which increased 1.2% and 0.8% respectively.The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which lost 5% and 2.7% respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Grifols (GRFS), which were down 1.8% and 1.7% respectively.The gainers from the UK were led by software firm Endava (DAVA) and biopharmaceutical company Akari Therapeutics (AKTX), which were up 2% and 1.6% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and pharmaceutical company AstraZeneca (AZN), which rose 1.2% and 1.5% respectively.The decliners from the UK and Ireland were led by mining company BHP Group (BHP) and biotech firm Trinity Biotech (TRIB), which fell 4.7% and 5.6% respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Biodexa Pharmaceuticals (BDRX), which dropped 2.2% and 3% respectively.

$AKTX$AMRN$AZN$BDRX$BHP$BNTX$CLLS$DAVA$DBVT$EVAX$FOCL$GRFS$MTLS$TRIB$TRVG$VOD
Asia Markets

European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were trending slightly higher late Tuesday morning, edging 0.05% to 1,953.79 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and petroleum refiner Equinor (EQNR), which rose 5.6% and 1.8%, respectively. They were followed by biopharmaceutical company Grifols (GRFS) and consumer goods company Unilever (UL), which were up 1% and 0.9%, respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Nokia (NOK), which fell 4% and 3.3% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and software firm SAP (SAP), which were down 2.1% and 1.9% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and oil and gas company BP (BP), which advanced 5.4% and 2.4% respectively. They were followed by biopharmaceutical company Amarin (AMRN) and tobacco company British American Tobacco (BTI), which increased 2.3% and 2% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which dropped 2.1% each. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and communications company WPP (WPP), which lost 2% and 1.9% respectively.

$AMRN$BDRX$BP$BTI$DBVT$EQNR$GRFS$MREO$NCNA$NOK$SAP$SQNS$TRIB$TRVG$UL$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, declining 0.46% to 1,977.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and biopharmaceutical company argenx (ARGX), which advanced 2.9% and 2.6% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and 3D printer company Materialise (MTLS), which rose 2% and 1.2% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and software firm SAP (SAP), which fell 3.5% and 2.7% respectively. They were followed by telecommunications company Ericsson (ERIC) and pharmaceutical company Novo Nordisk (NVO), which lost 2.1% and 1.8% respectively.The gainers from the UK were led by biopharmaceutical companies Amarin (AMRN) and Akari Therapeutics (AKTX), which climbed 7.1% and 2.9% respectively. They were followed by tobacco company British American Tobacco (BTI) and biopharmaceutical company Mereo BioPharma Group (MREO), which were up 1.8% and 0.7% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which dropped 14% and 3.9% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were down 2.2% and 1.8% respectively.

$AKTX$AMRN$ARGX$AUTL$BCYC$BDRX$BTI$DAVA$DBVT$ERIC$MREO$MTLS$NVO$SAP$SQNS$TRVG
Asia Markets

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were edging lower late Wednesday morning, declining 0.12% to 1,959.45 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which advanced 8.7% and 8.5%, respectively. They were followed by telecommunications company Ericsson (ERIC) and accommodations booking site trivago (TRVG), which rose 2.3% and 2.1%, respectively.The decliners from continental Europe were led by medical device maker EDAP (FOCL) and software company SAP (SAP), which shed 17% and 2.9%, respectively. They were followed by biotech firm Evaxion (EVAX) and pharmaceutical company Novo Nordisk (NVO), which fell 2.6% and 2.2%, respectively.The gainers from the UK were led by biopharmaceutical firms NuCana (NCNA) and Amarin (AMRN), which increased 4.9% and 1.6%, respectively. They were followed by lender Lloyds Banking Group (LYG) and utilities company National Grid (NGG), which were up 1.5% and 1.3%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Trinity Biotech (TRIB), which lost 7% and 5.8% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which dropped 3.3% and 2.7% respectively.

$AMRN$BDRX$DAVA$ERIC$EVAX$FOCL$LYH$MREO$NCNA$NGG$NOK$NVO$SAP$SQNS$TRIB$TRVG
Asia Markets

European Equities Traded in US as ADRs Ease in Wednesday Trading

European equities traded in the US as American depositary receipts eased late Wednesday morning with the S&P Europe Select ADR Index down 0.1% to 1,906.06.From continental Europe, the gainers were led by oil and gas company Eni (E) and energy company Equinor (EQNR), which climbed 6.9% and 6.2%, respectively. They were followed by software firm SAP (SAP) and travel-booking company trivago (TRVG), which increased 3% and 2.6%, respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and telecommunications company Nokia (NOK), which fell 4.8% and 3.6%, respectively. They were followed by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which dropped 2.5% and 2.3%, respectively.The gainers from the UK were led by software firm Endava (DAVA) and oil and gas company BP (BP), which rose 4.2% and 3.7%, respectively. They were followed by oil and gas company Shell (SHEL) and biopharmaceutical company Amarin (AMRN), which climbed 2.5% and 2.4%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which shed 25% and 4.6%, respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and lender Barclays (BCS), which lost 3.3% and 2.8%, respectively.

$AKTX$AMRN$BBVA$BCS$BDRX$BP$DAVA$E$EQNR$NOK$SAN$SAP$SHEL$SLN$SQNS$TRVG
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

European equities traded in the US as American depositary receipts were sharply higher late Thursday morning, advancing 2.21% to 1,927.62 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and biotech firm Evaxion (EVAX), which climbed 14% and 6.9% respectively. They were followed by biotech company BioNTech (BNTX) and biopharmaceutical company DBV Technologies (DBVT), which advanced 4.5% and 4.1% respectively.The only decliners from continental Europe were telecommunications company Nokia (NOK) and medical device maker EDAP (FOCL), which were down 1% and 0.8% respectively.The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and NuCana (NCNA), which rose 8.6% and 6.6% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company Silence Therapeutics (SLN), which were up 4.8% and 3.7% respectively.The only decliners from the UK and Ireland were biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Amarin (AMRN), which were off 1% and 0.3% respectively.

$AKTX$AMRN$AUTL$BDRX$BNTX$CLLS$DBVT$EVAX$FOCL$NCNA$NOK$SLN
Asia Markets

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.60% to 1,888.94 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies Cellectis (CLLS) and DBV Technologies (DBVT), which advanced 6% and 2.7% respectively. Also rising were internet advertising firm Criteo (CRTO) and biotech company Evaxion (EVAX), which increased 3.6% and 6.3% respectively.The decliners from continental Europe were led by telecommunications operator Nokia (NOK) and medical device maker EDAP TMS (FOCL), which fell 2.8% and 1% respectively. Anheuser-Busch InBev(BUD), which was off 1.2%.The gainers from the UK were led by biopharmaceutical company NuCana (NCNA) and software firm Endava (DAVA), which rose 3.2% and 2.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and oil and gas company BP (BP), which were up 1.4% and 1.1% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which lost 4.9% and 2.1% respectively. They were followed by biotech firmTrinity Biotech (TRIB), which dropped 0.3%.Biopharmaceutical company Amarin (AMRN) was modestly higher.

$AKTX$AMRN$BDRX$BP$BUD$CLLS$CRTO$DAVA$DBVT$EVAX$FOCL$MREO$NCNA$NOK$TRIB
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

European equities traded in the US as American depositary receipts started the week higher late Monday morning, advancing 0.61% to 1,903.57 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and telecommunications company Nokia (NOK), which rose 4.5% and 4.2% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical company DBV Technologies (DBVT), which were up 2.8% and 1.8% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Sanofi (SNY), which fell 5% and 2.8% respectively. They were followed by internet advertising firm Criteo (CRTO) and semiconductor company Sequans Communications (SQNS), which were down 2.6% and 2.4% respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Amarin (AMRN), which advanced 5.7% and 4.6% respectively. They were followed by lenders Lloyds Banking Group (LYG) and Barclays (BCS), which increased 4% and 3.8% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and mining company BHP Group (BHP), which lost 3.1% and 2% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and medical device maker Smith & Nephew (SNN), which dropped 1.8% and 0.8% respectively.

$AMRN$BCS$BHP$CLLS$CRTO$DBVT$LYG$NCNA$NOK$NVO$OPRA$SLN$SNN$SNY$SQNS$VOD
Asia Markets

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 0.80% to 1,882.97 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which rose 3.8% and 3.7% respectively. They were followed by healthcare tech company Royal Philips (PHG) and biopharmaceutical company Grifols (GRFS), which were up 2.9% and 2.5% respectively.The decliners from continental Europe were led by telecommunications company Ericsson (ERIC) and petroleum refiner Equinor (EQNR), which dropped 5% and 2.6% respectively. They were followed by telecommunications company Nokia (NOK) and SAP (SAP), which lost 1.5% and 1% respectively.The gainers from the UK were led by communications company WPP (WPP) and biopharmaceutical company Amarin (AMRN), which advanced 7.9% and 5.6% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 5.1% and 2.7% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and oil and gas company BP (BP), which fell 2.2% and 1.8% respectively. They were followed by oil and gas company Shell (SHEL) and lender HSBC (HSBC), which were down 1.3% and 1.1% respectively.

$AKTX$AMRN$BDRX$BP$CLLS$EQNR$ERIC$GRFS$HSBC$NOK$PHG$SAP$SHEL$SLN$SQNS$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biotech firm Evaxion (EVAX), which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago (TRVG) and telecommunications company Nokia (NOK), which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company Cellectis (CLLS), which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi (SNY) and biopharmaceutical company Grifols (GRFS), which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Amarin (AMRN), which were up 1.7% and 1.6% respectively.The decliners from the UK and Ireland were led by biotech company Autolus Therapeutics (AUTL) and biopharmaceutical company Mereo BioPharma Group (MREO), which dropped 4.2% and 2.4% respectively. They were followed by utilities company National Grid (NGG) and pharmaceutical company GSK (GSK), which lost 2% and 1.2% respectively.

$AMRN$AUTL$BDRX$BP$CLLS$EVAX$GRFS$GSK$MREO$NCNA$NGG$NOK$NVO$SNY$SQNS$TRVG
Sectors

Sector Update: Healthcare Stocks Climb Late Afternoon

Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index climbing 3.2% and the State Street Health Care Select Sector SPDR ETF (XLV) rising 3%.The iShares Biotechnology ETF (IBB) added 2.6%.In corporate news, Eli Lilly (LLY) shares gained 4.3% after Ascidian Therapeutics said Lilly will receive exclusive, target-specific rights to Ascidian's RNA exon editing technology for undisclosed kidney disease targets in exchange for up to $1.9 billion under a research partnership and licensing deal.Merck (MRK) shares climbed 5% after it said Thursday it will pay over $50 million to settle more than 200 lawsuits that blame the drugmaker's Gardasil cancer vaccine for causing autoimmune ailments in young women, Bloomberg reported.The US Supreme Court on Thursday ruled that Amarin (AMRN) failed to prove that a generic-drug manufacturer actively induced other companies to infringe upon two of its Vascepa patents after the generic maker received approval for a so-called "skinny-label" version of the drug. Amarin shares fell 4.4%.BofA Securities upgraded UnitedHealth (UNH) to buy from neutral as medical cost trends improve and "supportive" near-term data points form a favorable Q2. UnitedHealth shares rose 5.4%.

$AMRN$LLY$MRK$UNH
Sectors

Sector Update: Healthcare

Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index climbing 3.2% and the State Street Health Care Select Sector SPDR ETF (XLV) rising 2.9%.The iShares Biotechnology ETF (IBB) added 2.5%.In corporate news, the US Supreme Court on Thursday ruled that Amarin (AMRN) failed to prove that a generic-drug manufacturer actively induced other companies to infringe upon two of its Vascepa patents after the generic maker received approval for a so-called "skinny-label" version of the drug. Amarin shares fell 5.2%.

$AMRN
Wire

Update: Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case

(Updates with Amarin's response to a request for comment in the penultimate paragraph.)The US Supreme Court on Thursday ruled that Amarin (AMRN) failed to prove that a generic-drug manufacturer actively induced other companies to infringe upon two of its Vascepa patents after the generic maker received approval for a so-called "skinny-label" version of the drug.Vascepa received Food and Drug Administration approval in 2012 for treating severe hypertriglyceridemia before receiving the FDA's go-ahead in 2019 for a second, more common use: lowering cardiovascular risk in hypertriglyceridemia patients who take statins, the so-called CV indication, for which it received two patents, the Supreme Court noted.Hikma Pharmaceuticals received FDA approval for a generic icosapent ethyl skinny label in 2020 that carves out Vascepa's still-patented CV-indication method of use, the court noted."Amarin has failed to state a claim for active inducement in violation of *271(b), so its complaint cannot withstand Hikma's motion to dismiss," the Supreme Court said."We are deeply disappointed by the Supreme Court's decision today and are evaluating our next steps," Amarin toldin a statement. "Amarin remains fiercely dedicated to its primary mission: ensuring VASCEPA/VAZKEPA, a groundbreaking, innovative, and cost-effective therapy, reaches patients across the world who would benefit from this life-changing treatment."Hikma didn't immediately reply to a request for comment from.Price: $14.17, Change: $-0.36, Percent Change: -2.48%

$AMRN
Wire

Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case

The US Supreme Court on Thursday ruled that Amarin (AMRN) failed to prove that a generic-drug manufacturer actively induced other companies to infringe upon two of its Vascepa patents after the generic maker received approval for a so-called "skinny-label" version of the drug.Vascepa received Food and Drug Administration approval in 2012 for treating severe hypertriglyceridemia before receiving the FDA's go-ahead in 2019 for a second, more common use: lowering cardiovascular risk in hypertriglyceridemia patients who take statins, the so-called CV indication, for which it received two patents, the Supreme Court noted.Hikma received FDA approval for a generic icosapent ethyl skinny label in 2020 that carves out Vascepa's still-patented CV-indication method of use, the court noted."Amarin has failed to state a claim for active inducement in violation of *271(b), so its complaint cannot withstand Hikma's motion to dismiss," the Supreme Court said.The companies didn't immediately reply to requests for comment from.Price: $14.59, Change: $+0.06, Percent Change: +0.41%

$AMRN
Wire

Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case

Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case

$AMRN
Asia Markets

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

European equities traded in the US as American depositary receipts were trending slightly lower late Thursday morning, declining 0.1% to 1,873.2 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and medical device maker EDAP TMS (EDAP), which rose 3.3% and 3.2% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and software firm SAP (SAP), which were up 2.8% and 1.2% respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and brewing company Anheuser-Busch InBev (BUD), which fell 2.5% and 1.4% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and biotech firm BioNTech (BNTX), which were down 1.1% and 0.3% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Autolus Therapeutics (AUTL), which advanced 43.9% and 1.5% respectively. They were followed by communications company WPP (WPP) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which increased 0.9% and 0.3% respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and insurance company Prudential (PUK), which dropped 4.2% and 2.3% respectively. They were followed by lender HSBC (HSBC) and biopharmaceutical company Amarin (AMRN), which lost 2% and 0.6% respectively.

$AKTX$AMRN$AUTL$BDRX$BNTX$BUD$CLLS$CRTO$EDAP$GRFS$HSBC$NOK$PUK$SAP$SLN$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 0.73% to 1,891.94 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and telecommunications company Nokia (NOK), which rose 6.4% and 4.8% respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria (BBVA) and Banco Santander (SAN), which were up 4.4% and 3.8% respectively.The decliners from continental Europe were led by pharmaceutical company Ascendis Pharma (ASND) and petroleum refiner Equinor (EQNR), which fell 3% and 2% respectively. They were followed by internet advertising firm Criteo (CRTO) and pharmaceutical company Novo Nordisk (NVO), which were down 1.1% and 0.2% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which climbed 16% and 6.3% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which advanced 4.5% and 3.1% respectively.The decliners from the UK and Ireland were led by oil and gas company BP (BP) and biopharmaceutical company NuCana (NCNA), which dropped 5% and 2.4% respectively. They were followed by biopharmaceutical company Amarin (AMRN) and communications company WPP (WPP), which lost 1.6% and 1.5% respectively.

$AMRN$ASND$BBVA$BDRX$BP$CRTO$EQNR$MREO$NCNA$NOK$NVO$SAN$SLN$TRIB$TRVG$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

European equities traded in the US as American depositary receipts were heading higher late Monday morning, rising 0.88% to 1,825.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and healthcare tech company Royal Philips (PHG), which rose 4.6% and 2.9% respectively. They were followed by internet advertising firm Criteo (CRTO) and biopharmaceutical company Grifols (GRFS), which were up 2.8% each.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm BioNTech (BNTX), which dropped 3.2% and 2% respectively. They were followed by telecommunications company Nokia (NOK) and pharmaceutical company Ascendis Pharma (ASND), which were down 1.9% and 0.9% respectively.The gainers from the UK were led by biotech companies Autolus Therapeutics (AUTL) and Trinity Biotech (TRIB), which climbed 16% and 6.2% respectively. They were followed by communications company WPP (WPP) and educational publisher Pearson (PSO), which advanced 4.8% and 4.7% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which fell 8.3% and 3% respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Mereo BioPharma Group (MREO), which were off 2.1% and 1% respectively.

$AMRN$ASND$AUTL$BDRX$BNTX$CRTO$DBVT$EVAX$GRFS$MREO$NCNA$NOK$PHG$PSO$TRIB$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading

European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.43% to 1,852.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and 3D printer company Materialise (MTLS), which climbed 11.4% and 10.4% respectively. They were followed by lender ING Group (ING) and biopharmaceutical company Cellectis (CLLS), which increased 2.3% and 2.1% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and internet browser company Opera (OPRA), which fell 1.7% and 1.6% respectively. They were followed by oil and gas company Eni (E) and lender Banco Santander (SAN), which were off 1.3% and 0.5% respectively.The gainers from the UK were led by biopharmaceutical companies NuCana (NCNA) and Akari Therapeutics (AKTX), which advanced 9.6% and 3.2% respectively. They were followed by communications company WPP (WPP) and lender Barclays (BCS), which were up 2.8% and 2.4% respectively.The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and mining company BHP Group (BHP), which dropped 9.9% and 2.1% respectively. They were followed by biopharmaceutical company Amarin (AMRN) and pharmaceutical company AstraZeneca (AZN), which were down 1.3% each.

$AKTX$AMRN$AUTL$AZN$BCS$BHP$CLLS$E$ING$MTLS$NCNA$NVO$OPRA$SAN$SQNS$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which increased 4.9% and 3.2% respectively.The decliners from continental Europe were led by consumer goods company Unilever (UL) and biopharmaceutical company Grifols (GRFS), which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera (OPRA) and accommodations booking site trivago (TRVG), which were down 1% each.The gainers from the UK were led by cruise line operator Carnival (CUK) and pharmaceutical company Silence Therapeutics (SLN), which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Amarin (AMRN), which were up 3.9% and 3.4% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which lost 10% and 7.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software firm Endava (DAVA), which dropped 5.8% and 2.2% respectively.

$AKTX$AMRN$AUTL$BDRX$CLLS$CUK$DAVA$DBVT$ERIC$GRFS$MREO$OPRA$SLN$SQNS$TRVG$UL

Showing 1-20 of 27

Track with the FINWIRES app suite

FolioX
FolioX
Track AMRN in your portfolio
WheelAI
WheelAI
Analyze AMRN options with the wheel strategy
StockInsider
StockInsider
See market sentiment on AMRN